D-Propargyl-cysteine

D-Propargyl-cysteine is a D-configured cysteine derivative in which the thiol-bearing amino acid side chain is substituted with a propargyl group, yielding a chiral amino acid intermediate with an alkyne handle and a carboxylate functionality. The molecule contains a stereogenic center at the alpha carbon, a primary amine suitable for N-protection, and a sulfur-containing side chain that can be engaged in thiol chemistry or protected as a thioether/thiol equivalent depending on the synthetic form. The terminal alkyne provides a defined, orthogonally reactive functional group for click-type conjugation and for downstream elaboration into heterocycles or crosslinkable motifs. As a peptide-relevant amino acid analog, D-Propargyl-cysteine can be incorporated into peptide coupling sequences after appropriate protection of the amino and sulfur functionalities, enabling controlled stereochemical presentation in peptide scaffolds and biochemical probes.

1. Peptide Synthesis

D-Propargyl-cysteine supports peptide building workflows where cysteine-like side-chain chemistry and an alkyne-bearing substituent are needed for post-coupling diversification. The alpha-amino and carboxyl groups enable standard peptide coupling after N-protection and side-chain functional management, while the propargyl group can serve as a latent conjugation handle that survives common coupling conditions. Thiol-related reactivity can be controlled through sulfur protection strategies to prevent side reactions during activation and coupling, then carried forward into deprotected peptide analogs. Incorporation of the D-stereocenter allows access to D-amino acid-containing peptides for conformational tuning and protease-resistance studies, with the alkyne enabling orthogonal functionalization after assembly.

2. Bioconjugation Chemistry

D-Propargyl-cysteine is well suited to chemical biology workflows that require site-selective attachment of biomolecules via the terminal alkyne functionality. The propargyl group can participate in copper-catalyzed azide-alkyne cycloaddition or related alkyne-based ligation formats, while the amino acid backbone provides a handle for tethering to carriers through amide formation or activated ester chemistry after appropriate protection/deprotection. The D-configuration can be leveraged to generate stereochemically defined conjugates that may display altered stability toward enzymatic processing compared with L analogs. Downstream conjugate formation can produce labeled peptides, affinity probes, or modular linkers for mapping biomolecular interactions using amino acid-derived coupling chemistry.

3. Peptidomimetics And SAR Studies

D-Propargyl-cysteine enables peptidomimetic construction where cysteine-derived side-chain geometry and an alkyne substituent are used to probe structure-activity relationships. The combination of a protected amino acid framework with a chemically addressable alkyne supports iterative SAR campaigns by allowing late-stage diversification into triazole-linked motifs, crosslinkable units, or alkyne-to-heterocycle transformations. Side-chain sulfur functionality can be masked during synthesis to maintain coupling fidelity, then unmasked or transformed to tune polarity, reactivity, or binding-site presentation in analog libraries. Incorporation of the D-amino acid stereocenter supports stereochemical mapping of binding pockets and can be used to generate conformationally distinct peptide mimics for SAR evaluation.

4. Heterocycle Construction

D-Propargyl-cysteine can serve as an amino acid-derived precursor for heterocycle synthesis where the terminal alkyne functions as a key cyclization element. The propargyl group enables cycloaddition and annulation strategies that convert the side-chain alkyne into triazole, substituted aromatic, or other ring systems while retaining the amino acid-derived stereocenter for downstream incorporation. The presence of an amino and carboxyl functionality supports controlled derivatization into protected intermediates that can be carried through multi-step cyclization sequences without loss of stereochemical integrity. Resulting heterocycle-functionalized amino acid derivatives can then be used as building blocks for medicinal chemistry libraries, peptide analogs, and chemical probes requiring rigidified scaffolds.

5. Process Chemistry Intermediate

D-Propargyl-cysteine is applicable as a chiral amino acid intermediate for fine chemical synthesis routes that require an alkyne-functional building block with defined stereochemistry. The molecule's functional group set, including the carboxyl group for activation and the amino group for N-protection, supports scalable manufacturing strategies that separate protection, coupling, and functional-group conversion steps. The propargyl substituent provides a stable handle for downstream derivatization into conjugation-ready intermediates, while sulfur management through protection or controlled transformation helps reduce side reactions during scale-up. The resulting intermediate utility aligns with industrial workflows that prepare stereochemically defined amino acid derivatives for peptide-manufacturing supply chains and modular synthesis of functionalized small molecules.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Cationic cell-penetrating peptides are potent furin inhibitors

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics